Lv41
490 积分 2024-09-04 加入
糖尿病相关消化道症状的发病机制和临床诊疗进展
3小时前
已完结
Calcimimetic use in US hemodialysis facilities in first 2 years after the launch of etelcalcetide: A descriptive analysis of real-world clinical practice and outcomes
11小时前
已完结
Real World Use and Effects of Calcimimetics in Treating Mineral and Bone Disorder in Hemodialysis Patients
11小时前
求助中
Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathyroidism
11小时前
已完结
Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism A Randomized Clinical Trial
11小时前
已完结
Pharmacology of Parsabiv® (etelcalcetide, ONO-5163/AMG 416), a novel allosteric modulator of the calcium-sensing receptor, for secondary hyperparathyroidism in hemodialysis patients
11小时前
已完结
糖尿病相关消化道症状的发病机制和临床诊疗进展
2天前
已完结
中国糖尿病合并慢性肾脏病临床管理共识
6天前
已完结
Costa-Moreira P, Vilas-Boas F, Teixeira Fraga A, Macedo G. Particular aspects of gastroenterological disorders in chronic kidney disease and end-stage renal disease patients: a clinically focused review. Scand J Gastroenterol. 2020 Feb;55(2):129-138
6天前
已完结
慢性肾脏病上消化道出血研究进展
6天前
已完结
皖公网安备34019202002308
